Sufentanil Citrate Injection recall: Subpotent
Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit forming…
Why was Sufentanil Citrate Injection recalled?
Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 031489A, Expiration 03/31/2022
- Product
- Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit forming…
- Recalling firm
- Akorn, Inc.
- Quantity
- 31,510 ampules
- Distribution
- Nationwide in the USA
- Recall date
- January 19, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)